Company: SXTPW
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001554855-25-001009
Chunk: 2

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
60 DEGREES PHARMACEUTICALS, INC.

CONSOLIDATED CONDENSED BALANCE SHEETS

 June 30, 2025 December 31, (Unaudited) 2024ASSETS:     Current Assets:     Cash and Cash Equivalents$1,966,930 $1,659,353Accounts Receivable 295,034  486,748Prepaid and Other Assets 782,970  1,068,940Short-Term Investments -  1,728,472Inventory (Note 3) 799,421  442,764Total Current Assets 3,844,355  5,386,277Property and Equipment, net (Note 4) 193,879  149,808Other Assets:     Long-Term Prepaid Expense -  66,176Intangible Assets, net (Note 5) 143,704  157,084Total Other Assets 143,704  223,260Total Assets$4,181,938 $5,759,345LIABILITIES AND SHAREHOLDERS' EQUITY:     Current Liabilities:     Accounts Payable and Accrued Expenses$905,813 $1,007,618SBA EIDL (including accrued interest) (Note 7) 8,772  8,772Derivative Liabilities (Note 8) 776,172  640,830Total Current Liabilities 1,690,757  1,657,220Long-Term Liabilities:     SBA EIDL (including accrued interest) (Note 7) 145,477  147,119Total Long-Term Liabilities 145,477  147,119Total Liabilities 1,836,234  1,804,339Commitments and Contingencies (Note 11)     SHAREHOLDERS' EQUITY:     Series A Preferred Stock, $0.0001 par value, 1,000,000 shares authorized; 76,480 and 76,480 issued and outstanding as of June 30, 2025 and December 31, 2024, respectively (Note 6) 9,567,439  9,567,439Common Stock, $0.0001 par value, 150,000,000 shares authorized; 1,472,